**Tata Chemicals Q3 FY26 Brief: Loss Widens Amid Market Headwinds** **Financial Performance Overview** Tata Chemicals reported a consolidated net loss of **Rs 93 crore** for the quarter ended December 31, 2025, widening significantly from the **Rs 53 crore** loss recorded in the same period last year. The results, announced today, reflect persistent challenges in the global chemical environment. Consolidated revenue from operations dipped marginally by **1.11%** to **Rs 3,550 crore**, down from **Rs 3,590 crore** in the previous year, as the company grappled with pricing pressures across key international markets. **Operational Challenges** The core impact on profitability stems from the soda ash segment, which continues to face an oversupply situation globally. Management highlighted that high inventory levels across most regions have kept prices soft, particularly in export markets like Southeast Asia. The adverse demand-supply dynamics have created a subdued near-term outlook, with limited visibility on immediate price recovery. While the UK operations have completed their reconfiguration toward value-added products, the broader international business remains weighed down by unsustainable low realizations. **Domestic Resilience & Strategic Investments** In contrast to the consolidated figures, the company’s standalone performance in India demonstrated resilience. Supported by higher volumes and disciplined cost management, the domestic business maintained stability. The Board has approved a significant capital allocation of **Rs 515 crore** to set up a greenfield manufacturing facility for Iodised Vacuum Salt Dried (IVSD) in Valinokkam, Tamil Nadu. This plant, with a planned capacity of **210 kilo tonnes per annum**, underscores a strategic pivot toward strengthening the consumer products portfolio and meeting growing domestic demand for high-quality salt. **Acquisition & Expansion** Aligning with its strategy to move up the value chain, Tata Chemicals is proceeding with the acquisition of **Novabay Pte. Limited**, a Singapore-based specialty chemical manufacturer. The deal, valued at approximately **EUR 25 million** (roughly **Rs 260 crore**), targets the premium sodium bicarbonate market. Novabay’s portfolio caters to high-margin sectors such as pharmaceuticals, personal care, and food processing. The transaction is expected to close in the fourth quarter of FY26, reinforcing the company's foothold in non-cyclical, high-value segments. **Market Reaction** Investor sentiment remained cautious following the earnings announcement. Shares of Tata Chemicals closed at **Rs 726.15** on the BSE today, marking a decline of **2.27%**. The stock has faced pressure over the past year, shedding nearly a quarter of its value as the commodity cycle turned unfavorable. **Future Outlook** Management has reiterated a focus on protecting margins and preserving cash flows during this downturn. The strategy involves a disciplined approach to capital allocation and cost control while expanding the specialty chemicals footprint. With the soda ash cycle remaining uncertain, the company is betting on its consumer and specialty businesses to drive long-term stability and reduce reliance on volatile commodity markets.